Table 3.
Individual patient data of neoadjuvant chemotherapy
| Name | Case 1 | Case 2 |
|---|---|---|
| Sex | Male | Female |
| Age | 40 | 72 |
| Histologic category | Synovial sarcoma | Sarcomatoid malignant mesothelioma |
| Surgery history | Yes | No |
| Chemotherapy history | No | No |
| Maximum diameter of tumor | 5.8 cm | 12.4 cm |
| Chemotherapy | AIM + Endostar + Anlotinib | AIM + Anlotinib |
| First time | September 17th, 2019 | September 17th, 2019 |
| Toxicity profile | – | Nausea/Vomiting (I) |
| Second time | October 9th, 2019 | October 9th, 2019 |
| Toxicity profile | – | Nausea/Vomiting (I) |
| Maximum diameter of tumor | 3.5 cm | 7.5 cm |
| Response | PR | PR |
| Third time | October 31th,2019 | October 31th,2019 |
| Toxicity profile | – | Febrile neutropenia (IV) |
| Fourth time | 2019.11.22 | – |
| Toxicity profile | Neutropenia (I) | – |
| Maximum diameter of tumor | 2.8 cm | 8.1 cm |
| Response | PR | PR |
| Surgery | December 23th, 2019(R0) | December 16th, 2019(R0) |